title: First FDA authorization for next-generation sequencer.
authors.affiliation: From the Office of the Director, National Institutes of Health, Bethesda, MD (F.S.C.); and the Office of the Commissioner, Food and Drug Administration, Department of Health and Human Services, Silver Spring, MD (M.A.H.).
authors.forename: Francis S
authors.initials: FS
authors.lastname: Collins
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Hamburg
mesh_terms: D018795:Device Approval / Q000331:legislation & jurisprudence; D015894:Genome, Human; D006801:Humans; D010597:Pharmacogenetics; D057285:Precision Medicine; D017422:Sequence Analysis, DNA / Q000191:economics / Q000295:instrumentation* / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration